Elizabeth McKiernan, Elijah Mak, MAria Eleni-Dounavi, Katie Wells, Craig Ritchie, Guy Williams, Li Su, John O’Brien
Journal of Neurology, Neurosurgery and Psychiatry. 2020
Michael Firbank, John O’Brien, Karen Ritchie, Katie Wells, Guy Williams, Li Su, Craig Ritchie
Journal of Neurology. 2020
Anna McKeever, Alvar Paris, James Cullen, Lawrence Hayes, Craig Ritchie, Karen Ritchie, Adam Waldman, Katie Wells, Albert Busza, Isabelle Carriere, John O’Brien
Journal of Alzheimer’s Disease. 2020
Maria-Eleni Dounavi, Elijah Mak, Katie Wells, Karen Ritchie, Craig W. Ritchie, Li Su, John T.O’ Brien
Neurobiology of Ageing. 2020
John T O’Brien, Michael J Firbank, Karen Ritchie,, Katie Wells, Guy B Williams, Craig W Ritchie, Li Su
Journal of Neurology, Neurosurgery & Psychiatry. 2019
Individuals with a higher likelihood of developing Alzheimer’s disease dementia in the future, as predicted by their mid-life CAIDE score, show more shrinkage of brain volume, measured over the course of two years.Read More
Known risk factors for heart disease, an individual’s genetic makeup as well as other health factors, are thought to contribute to someone’s risk of developing Alzheimer’s disease (AD). Researchers have put together a scoring system that uses these risk factors in midlife to calculate someone’s risk of developing Alzheimer’s disease dementia in the future. This is known as a CAIDE score.
The authors used data from the first 210 PREVENT participants from the West London group. The participants were split into two groups based on their CAIDE score and each participant had an MRI scan to look at their brain at two time points, their initial visit and then two years later. The researchers found that the group of participants with a CAIDE score of 7 and above showed more overall shrinkage in their brain after two years compared to people with a lower score.
The authors therefore were able to demonstrate that there is an association between CAIDE score and brain volume and that individuals with a higher CAIDE score in midlife are already showing signs of brain changes. It also provides evidence that using an MRI scanner to image individuals thought to be at risk every few years and measuring brain changes, or lack thereof, may be a good way to track disease progression, or how well an intervention is working.
Hinesh Topiwala, Graciela Muniz Terrera, Lucy Stirland, Kathryn Saunderson, Tom C. Russ, Marshall F. Dozier and Craig W. Ritchie
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 2018